FyoniBio is a contract development organization and clinical laboratory offering smart and custom-tailored services at different drug development stages to pharmaceutical and biotechnology companies. FyoniBio operates as the newly formed service branch of Glycotope.Based on 20 years of experience, we provide ISO-9001:2015 fully-integrated services from cell line engineering over process development and drug quality control up to broad bioanalytical capabilities for preclinical and clinical studies.A special focus lies on drug glycosylation as this is a critical quality attribute of biopharmaceuticals which can affect drug clearance, potency and safety as well as productivity. All these aspects are addressed by FyoniBio´s human GlycoExpress cells as well as the CHO platform technology CHOnamite coupled with upstream and downstream process optimization, state-of-the-art equipment and in-house developed software for glycan analytics.The service portfolio is complemented by GCLP-compliant bioanalysis of clinical samples including pharmacokinetics, genotyping, biomarker and immunogenicity assessment.